A science journal has deemed over one hundred research papers from China to be “fabricated” and retracted all of them from publication.
International publisher Springer Nature found that 107 research papers submitted by Chinese authors had been “compromised” and must be removed from the records, Mashable reports.
The retracted articles were published by the company in the journal Tumor Biology from 2012 to 2016.
According to Springer Nature editorial director for cell biology and biochemistry Peter Butler, while the papers were submitted to names of real reviewers, the email addresses used were fabricated.
“We are retracting these published papers because the peer review process required for publication in our journals had been deliberately compromised by fabricated peer reviewer reports,” Springer Nature stated according to RetractionWatch.
An investigation revealed that the real reviewers listed in the articles have denied conducting peer reviews in any of them. A huge percentage of the questionable articles involved cancer research from authors who all hail from Chinese organizations.
Fakery in Chinese research is not new. Last year, it was found that over 80% of the data used in clinical trials of new pharmaceutical drugs in China have been “fabricated”. The government investigation found that the data failed to meet analysis requirements, were incomplete, or totally non-existent.